GDNF and Parkinson disease: The co-administrationof glial cell line-derived neurotrophic factor(GDNF) and mesenchymal stem cells (MSCs) in hydrogels (HGs) has emergedas a powerful strategy to enhance the efficient integration of transplantedcells in Parkinson’s disease (PD).